ArticleEuropean radiology2026
1.5-T MR imaging of organic laryngotracheal stenosis in a pediatric cohort predominantly younger than 7 years: protocol optimization and diagnostic performance.
Article in European radiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveTo develop a 1.5-T MR imaging protocol tailored for organic laryngotracheal stenosis (LTS) and to assess its performance in visualizing anatomy and pathologies. MATERIALS AND
methodsPresurgical laryngotracheal 1.5-T MR imaging was prospectively conducted in a cohort of 78 children with organic LTS from September 2021 to July 2023. Dedicated sequences were employed to acquire anatomical images of the laryngotracheal region. Image quality was assessed both qualitatively and quantitatively. Using intraoperative findings from laryngotracheal reconstruction (LTR) as the gold standard, the accuracy of preoperative MR imaging measurements of the cricoid cartilage and pathological diagnoses was evaluated.
resultsThe average age of seventy-eight children was 3.38 ± 2.95 years. Image quality of the larynx and cervical trachea was rated fair or good in 94.9% (74/78) and 96.2% (75/78) of cases, respectively. Interobserver agreement was high (Kappa ≥ 0.81). For 59 children with a score of 3, RTr-FSE-T2WI images presented significantly better signal-to-noise and contrast-to-noise ratios (p < 0.001). Compared with the surgical findings, MR imaging revealed no significant differences in the cricoid plate height, cricoid arch thickness, or short diameter of the narrowest laryngotracheal lumen (p > 0.05), except for the cricoid plate thickness (p = 0.002). Diagnostic accuracies of MR imaging for glottic, subglottic, and tracheal scars were 89.7%, 89.7% and 94.9%, respectively. For tracheomalacia and tracheoesophageal fistula, the accuracies were 85.9% and 97.4%, respectively.
conclusionsOptimized 1.5-T MR imaging provides high-quality anatomical images, serving as a valuable imaging modality for preoperative evaluation of pediatric organic LTS. KEY POINTS: Question The current imaging techniques used for preoperatively evaluating laryngotracheal conditions in children have notable limitations. Accurate evaluation primarily depends on intraoperative laryngoscopy. Findings The optimized 1.5-T MR sequence provides good contrast between normal and abnormal laryngotracheal tissues, facilitating precise presurgical evaluation of anatomical and structural abnormalities. Clinical relevance The 1.5-T MR sequence package is suitable for the preoperative evaluation of pediatric LTS. It provides detailed information on the cause and severity of stenosis and enables precise measurement of cricoid cartilage dimensions, aiding accurate surgical planning.
Indexed as
Identifiers
40911064What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.